What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Immune system
Immunology, Rituximab, Molecular biology, Antigen and CD20 are her primary areas of study.
Her research on Immunology frequently connects to adjacent areas such as B-1 cell.
Her Rituximab study incorporates themes from Cancer research, CD59 and Monoclonal.
Her study in Molecular biology is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Peripheral blood mononuclear cell, Exon, RNase P and Signal peptide.
She has researched CD20 in several fields, including Chronic lymphocytic leukemia and Immunotherapy.
Her Antibody study integrates concerns from other disciplines, such as Phagocytosis and Cytotoxicity.
Her most cited work include:
- Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis (551 citations)
- Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis (551 citations)
- Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo (473 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Immunology, Molecular biology, Cancer research, CD20 and Rituximab.
The study incorporates disciplines such as Cytotoxic T cell and Cytotoxicity in addition to Immunology.
Josée Golay has included themes like CD59 and Complement system in her Cytotoxicity study.
Her Molecular biology study combines topics in areas such as Cell culture, MYB, Gene expression, Gene and Cell growth.
Her studies in CD20 integrate themes in fields like Alemtuzumab and Chronic lymphocytic leukemia.
Her Rituximab research includes elements of Bone marrow and Monoclonal.
She most often published in these fields:
- Immunology (39.84%)
- Molecular biology (30.47%)
- Cancer research (20.31%)
What were the highlights of her more recent work (between 2013-2021)?
- Mesenchymal stem cell (10.16%)
- Cancer research (20.31%)
- Immunology (39.84%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Mesenchymal stem cell, Cancer research, Immunology, Internal medicine and Antigen.
Her research in Cancer research tackles topics such as Cytotoxic T cell which are related to areas like T cell, CD3 and Cord blood.
Her Chronic lymphocytic leukemia and Antibody study in the realm of Immunology interacts with subjects such as HLA-DR Antigen.
Her Internal medicine research incorporates elements of Gastroenterology and Surgery.
The Antigen study combines topics in areas such as In vitro, Tumor microenvironment, Pharmacodynamics, Monoclonal antibody and Drug.
Her work in Molecular biology tackles topics such as Cytotoxicity which are related to areas like Cell biology.
Between 2013 and 2021, her most popular works were:
- Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. (139 citations)
- Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy (109 citations)
- Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies (49 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
Chronic lymphocytic leukemia, CD20, Immunology, Cell therapy and Obinutuzumab are her primary areas of study.
Many of her studies on Chronic lymphocytic leukemia apply to Antigen as well.
Her research integrates issues of Phagocytosis and Opsonin in her study of Antigen.
The concepts of her Cell therapy study are interwoven with issues in Gastroenterology, Internal medicine and Mesenchymal stem cell, Pathology.
To a larger extent, Josée Golay studies Antibody with the aim of understanding Obinutuzumab.
Her Leukemia research focuses on In vitro and how it relates to Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
